Additionally, we observed that plumbagin therapy reduced the ratio of LC3-II/LC3-I and the expression levels of autophagy substrate p62 and p-mTOR proteins in chronic PD rats caused by MPTP and probenecid (Figures 4(c) and 4(d)). This evidence concerns the gene MTOR and Parkinson disease.